Respiratory Care: Mechanical Ventilators and Pulmonary Function Testing Systems
Respiratory Care: Mechanical Ventilators and Pulmonary Function Testing Systems
$4,750.00
Asthma and COPD affect an estimated 590 million people worldwide, with an additional 114 million affected by COVID-19 from March 2020 to March 2021. Devices used in the diagnosis and treatment of these and other respiratory disorders include mechanical ventilators and pulmonary function testing systems.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Executive Summary
Pulmonary conditions that may require respiratory therapy include acute respiratory distress syndrome, asthma, chronic obstructive pulmonary disease (COPD; which includes chronic bronchitis and emphysema), cystic fibrosis, pneumonia, respiratory failure, restrictive lung disease, tuberculosis (TB), and COVID-19. Non-pulmonary conditions that may require continuous respiratory therapy include neuromuscular disorders such as those associated with amyotrophic lateral sclerosis, poliomyelitis, scoliosis, and spinal cord injury. According to the World Health Organization (WHO), the two most prevalent respiratory diseases, asthma and COPD, affect more than 590 million people worldwide.
Device types utilized in the diagnosis and treatment of these pulmonary conditions include mechanical ventilators and pulmonary function assessment products.
Overview
Asthma and COPD affect an estimated 590 million people worldwide, with an additional 114 million affected by COVID-19 from March 2020 to March 2021. Devices used in the diagnosis and treatment of these and other respiratory disorders include mechanical ventilators and pulmonary function testing systems. The combined global market for full-featured mechanical ventilators was estimated at $850m in 2019, with explosive multifold growth in 2020 as a result of the COVID-19 pandemic, and an expected return to typical growth patterns beginning in 2021. In the pulmonary function testing systems market, closure of testing facilities due to COVID-19 resulted in a significant revenue loss for major competitors. Although many laboratories reopened in late 2020, ongoing safety precautions continue to contribute to a slow market recovery. This report provides a discussion of products, current/forecast markets, competitors, and opportunities in these global markets for the US, five major European markets, Japan, and rest-of-world markets for 2019–25.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. Ventilators ……………………………………………………………………………………………………. ES-1
ii. Pulmonary function testing systems…………………………………………………………………. ES-4
iii. Major competitors………………………………………………………………………………………… ES-4
iv. Methodology……………………………………………………………………………………………….. ES-5
Exhibit ES-1: Full-featured mechanical ventilators, market forecast ($m), by region, 2019–25…………………………………………………………………………………. ES-3
1. Respiratory Disease Overview ……………………………………………………..1-1
1.1 Asthma…………………………………………………………………………………………………………1-1
1.1.1 Etiology…………………………………………………………………………………………..1-1
1.1.2 Epidemiology…………………………………………………………………………………..1-2
1.2 Chronic obstructive pulmonary disease ……………………………………………………………..1-2
1.2.1 Etiology…………………………………………………………………………………………..1-3
1.2.2 Epidemiology…………………………………………………………………………………..1-3
1.3 COVID-19 ……………………………………………………………………………………………………..1-4
1.3.1 Etiology…………………………………………………………………………………………..1-4
1.3.2 Epidemiology…………………………………………………………………………………..1-5
1.4 Bibliography………………………………………………………………………………………………….1-8
Exhibit 1-1: Asthma epidemiology, 2016 and 2036 ……………………………………………………1-2
Exhibit 1-2: COPD epidemiology, 2018 and 2038 ………………………………………………………1-4
Exhibit 1-3: COVID-19 epidemiology, 2020–21………………………………………………………….1-7
2. Mechanical Ventilators ………………………………………………………………2-1
2.1 Types of mechanical ventilators………………………………………………………………………..2-1
2.1.1 Risks ……………………………………………………………………………………………..2-2
2.1.2 Application in COVID-19…………………………………………………………………….2-2
2.1.3 Neonatal and transport ventilators ……………………………………………………..2-5
2.2 Full-featured ventilators………………………………………………………………………………….2-8
2.2.1 Products …………………………………………………………………………………………2-9
2.2.2 Market forecast ……………………………………………………………………………..2-14
2.2.3 Competitive analysis……………………………………………………………………….2-16
2.3 Emerging technologies………………………………………………………………………………….2-22
2.4 Bibliography………………………………………………………………………………………………..2-24
Exhibit 2-1: Selected full-featured mechanical ventilators, 2021………………………………..2-12
Exhibit 2-2: Full-featured mechanical ventilators, market forecast ($m), by region, 2019–25………………………………………………………………………………….2-15
Exhibit 2-3: Koninklijke Philips, revenues by segment, FY2019…………………………………..2-17
Exhibit 2-4: Medtronic, revenues by segment, FY2020 …………………………………………….2-18
Exhibit 2-5: Getinge, revenues by segment, FY2019…………………………………………………2-19
Exhibit 2-6: Dräger Medical, revenues by segment, FY2019………………………………………2-21
Exhibit 2-7: Full-featured mechanical ventilators market, share by supplier, 2019………..2-21
3. Pulmonary Function Assessment Products……………………………………..3-1
3.1 Application in COVID-19 ………………………………………………………………………………….3-3
3.2 Diagnostic spirometers……………………………………………………………………………………3-4
3.2.1 Products and technology……………………………………………………………………3-4
3.3 Pulmonary function testing systems………………………………………………………………….3-7
3.3.1 Products and technology……………………………………………………………………3-7
3.4 Emerging technologies………………………………………………………………………………….3-12
3.5 Bibliography………………………………………………………………………………………………..3-14
Exhibit 3-1: Lung volumes and capacities…………………………………………………………………3-2
Exhibit 3-2: Selected diagnostic spirometers, 2021……………………………………………………3-6
Exhibit 3-3: Selected pulmonary function testing systems, 2021………………………………..3-11
Appendix: Company Listing……………………………………………………………. A-1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Diabetes Management: Blood Glucose Monitoring Devices Market (2021) 
Sign up to the